Alaska Permanent Fund
Juneau, Alaskaapfc.org
Overview
Alaska Permanent Fund is a sovereign wealth fund established in 1976 from Alaska's oil revenues, which invests globally across a diversified portfolio of public and private asset classes, including public equities, fixed income, private equity, real estate, and infrastructure.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kenai Therapeutics | Feb 2024 | Series A | Lead |
| Tessera Therapeutics | Apr 2022 | Series C | Co-investor |
| Generate Biomedicines | Nov 2021 | Series B | Co-investor |
| Repertoire Immune Medicines | Apr 2021 | Series B | Co-investor |
| Tessera Therapeutics | Jan 2021 | Series B | Lead |
Key People
Ed Rime
Portfolio Manager
Joshua Ungar
Portfolio Manager, Private Equity
Matthew Olmsted
Senior Portfolio Manager
Ross Alexander
Portfolio Manager
Stephen A.
Senior Portfolio Manager
Steven Gagliardo
Portfolio Manager - Private Equity
Tom O'Day
Portfolio Manager
Tom ODay
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
